Glaxo announces drug research projects in Siena
(AGI) Siena, Feb 20 - Multinational drug giant GlaxoSmithKline(GSK) is to fund research into innovative drug development atthe University of Siena in Italy. Dr Duncan Holmes, EuropeanHead of the Discovery Partnerships with Academia researchprogramme, will present 11 research projects at the universityon Wednesday. These will include anti-cancer drugs and drugsfor combating serious diseases, such as multiple sclerosis andRett syndrome. Research will also be undertaken intoantibiotic-resistant bacteria. The university said theprogramme was a first step in a long-term collaboration betweenthe university and GSK, which would involve research proposalsusing shared skills,